Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

96.46
Delayed Data
As of May 25
 -1.22 / -1.25%
Today’s Change
29.46
Today|||52-Week Range
108.00
+64.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line34.4M79.0M21.7M17.7M
 
 
 
 
 
Depreciation352.0K639.0K1.7M2.1M
 
 
 
 
 
Total Other Cash Flow-12.4M13.9M8.6M12.5M
 
 
 
 
 
Funds From Operations22.4M93.5M29.6M30.7M
 
 
 
 
 
Funds From/For Other Operating Expenses2.3M16.8M-6.2M-22.0M
 
 
 
 
 
Net Cash Flow - Operating Activities20.2M76.7M35.8M52.7M
 
 
 
 
 
 
InvestingIncrease In Investments-98.4M-196.3M-192.4M-251.4M
 
 
 
 
 
Decrease In Investments99.9M110.6M153.5M249.3M
 
 
 
 
 
Capital Expenditures-1.0M-2.3M-4.7M-2.5M
 
 
 
 
 
Fixed Asset Disposal3.0K9.0K----
 
 
 
Other Investing - Uses0.00-172.0K0.000.00
 
 
Net Cash Flow Investing497.0K-88.2M-43.7M-4.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.000.00--
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.00-68.0K-73.0K
 
 
 
Net Proceeds Stock Sale1.1M726.0K1.7M1.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing110.0K1.8M1.0M213.0K
 
 
 
 
 
Other Uses - Financing--0.00--202.0K
 
 
Net Cash Flow - Financing1.2M2.5M2.7M1.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash21.8M-9.0M-5.1M49.1M